Szarvas T - Search Results

1

[Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder].

vom Dorp F, Börgermann C, Schenck M, Becker M, Rose A, Szarvas T, Rübben H. vom Dorp F, et al. Among authors: szarvas t. Urologe A. 2009 Jan;48(1):51-3. doi: 10.1007/s00120-008-1760-z. Urologe A. 2009. PMID: 19048222 Review. German.

2

Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation: a systematic review and meta-analysis.

Szabó A, Váncsa S, Hegyi P, Váradi A, Forintos A, Filipov T, Ács J, Ács N, Szarvas T, Nyirády P, Kopa Z. Szabó A, et al. Among authors: szarvas t. Reprod Biol Endocrinol. 2023 Jan 18;21(1):5. doi: 10.1186/s12958-023-01054-0. Reprod Biol Endocrinol. 2023. PMID: 36653793 Free PMC article. Review.

3

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.

Varadi M, Nagy N, Reis H, Hadaschik B, Niedworok C, Modos O, Szendroi A, Ablat J, Black PC, Keresztes D, Csizmarik A, Olah C, Gaisa NT, Kiss A, Timar J, Toth E, Csernak E, Gerstner A, Mittal V, Karkampouna S, Kruithof de Julio M, Gyorffy B, Bedics G, Rink M, Fisch M, Nyirady P, Szarvas T. Varadi M, et al. Among authors: szarvas t. Cancer Med. 2023 Apr;12(7):9041-9054. doi: 10.1002/cam4.5639. Epub 2023 Jan 20. Cancer Med. 2023. PMID: 36670542 Free PMC article.

4

[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].

Jäger T, Szarvas T, vom Dorp F, Börgermann C, Schenck M, Schmid KW, Rübben H. Jäger T, et al. Among authors: szarvas t. Urologe A. 2007 Sep;46(9):1152-6. doi: 10.1007/s00120-007-1429-z. Urologe A. 2007. PMID: 17593336 German.

5

[The revival of "uroscopy": an easy way to evaluate the anastomotic region after radical retropubic prostatectomy].

Schenck M, Szarvas T, Ruebben H, Jaeger T. Schenck M, et al. Among authors: szarvas t. Urologe A. 2008 Mar;47(3):331-6. doi: 10.1007/s00120-007-1615-z. Urologe A. 2008. PMID: 18210070 German.

6

Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.

Szarvas T, Jäger T, Droste F, Becker M, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Pathol Oncol Res. 2009 Jun;15(2):193-201. doi: 10.1007/s12253-008-9107-z. Epub 2008 Sep 20. Pathol Oncol Res. 2009. PMID: 18807212 Free article.

7

Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.

Szarvas T, Jäger T, Tötsch M, vom Dorp F, Kempkensteffen C, Kovalszky I, Romics I, Ergün S, Rübben H. Szarvas T, et al. Clin Cancer Res. 2008 Dec 15;14(24):8253-62. doi: 10.1158/1078-0432.CCR-08-0677. Clin Cancer Res. 2008. PMID: 19088043

8

[Urine-based markers of angiogenesis in bladder cancer].

Becker M, Tilki D, Szarvas T, Rübben H, Ergün S. Becker M, et al. Among authors: szarvas t. Urologe A. 2009 Jun;48(6):609-14. doi: 10.1007/s00120-009-1989-1. Urologe A. 2009. PMID: 19557465 Review. German.

9

[Urine-based cytological diagnosis against the background of the new histopathological classification].

Tschirdewahn S, Boergermann C, Becker M, Szarvas T, Rübben H, vom Dorp F. Tschirdewahn S, et al. Among authors: szarvas t. Urologe A. 2009 Jun;48(6):615-8. doi: 10.1007/s00120-009-1990-8. Urologe A. 2009. PMID: 19557466 German.

10

[The value of urinary cytology in the diagnosis of high grade urothelial tumors].

Niedworok C, Rembrink V, Hakenberg OW, Börgermann C, Rossi R, Schneider T, Becker M, Szarvas T, von Ostau C, Swoboda A, Rübben H, vom Dorp F. Niedworok C, et al. Among authors: szarvas t. Urologe A. 2009 Sep;48(9):1018, 1020-2, 1024. doi: 10.1007/s00120-009-2077-2. Urologe A. 2009. PMID: 19697005 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters